Home › Trial NCT00324415
Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
- Trial IDNCT00324415
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorAIDS Malignancy Consortium
- Enrollment45
- Start date2006-09
- ConditionsAnal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.